骨髓增殖性肿瘤中血栓形成、微血管病变与出血的病理生物学
该综述阐述费城染色体阴性骨髓增殖性肿瘤(MPN)中血栓、血管及出血并发症的病理机制。MPN驱动突变(如JAK2 V617F)导致血细胞和内皮细胞内在异常,激活后形成促黏附促血栓环境,引发静脉、动脉及微血管血栓。出血源于获得性血管性血友病,炎症状态放大血栓倾向并促进克隆扩增,形成恶性循环。
要点
- MPN驱动突变使血细胞和内皮细胞内在异常,激活后形成促血栓环境。
- 血栓可累及静脉、动脉及微血管,是MPN主要致残致死原因。
- 出血由MPN血细胞引发的获得性血管性血友病所致。
核心结论
- MPN中血栓、微血管病变和出血并发症由驱动突变相关的细胞内在异常及炎症微环境共同驱动,形成促血栓恶性循环。
研究设计与样本
- 综述,总结费城染色体阴性MPN血栓与出血并发症的病理生物学机制。
主要发现
- 循环红细胞、白细胞、血小板及部分血管内皮细胞携带MPN驱动突变(如JAK2 V617F)相关的细胞内在异常。
- 这些细胞在MPN中激活后相互作用,在循环中形成高度促黏附和促血栓环境,易致静脉、动脉及微血管血栓和闭塞性疾病。
- MPN出血问题由MPN血细胞引发的获得性血管性血友病所致。
- MPN干细胞在微环境中产生的炎症状态可系统性放大临床血栓倾向,同时优先促进MPN干细胞克隆扩增,形成促血栓恶性循环。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombotic, vascular, and bleeding complications are the most common causes of morbidity and mortality in the Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs). In these disorders, circulating red cells, leukocytes, and platelets, as well as some vascular endothelial cells, each have abnormalities that are cell-intrinsic to the MPN driver mutations they harbor (eg, JAK2 V617F). When these cells are activated in the MPNs, their interactions with each other create a highly proadhesive and prothrombotic milieu in the circulation that predisposes patients with MPN to venous, arterial, and microvascular thrombosis and occlusive disease. Bleeding problems in the MPNs are caused by the MPN blood cell-initiated development of acquired von Willebrand disease. The inflammatory state created by MPN stem cells in their microenvironment extends systemically to amplify the clinical thrombotic tendency and, at the same time, preferentially promote further MPN stem cell clonal expansion, thereby generating a vicious cycle that favors a prothrombotic state in these diseases.
引用
- Hasselbalch HC, Elvers M, Schafer AI, et al. The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms. Blood. 2021. PMID: 33649757. doi:10.1182/blood.2020008109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。